Company intelligence / Profile preview

MetaStem Therapeutics

Vancouver, British Columbia, Canadaadvancedbiogen.com ↗

Ownership: Private
Development stage: Preclinical

Overview

MetaStem Therapeutics, a University of British Columbia startup, collaborates with academic and industry partners to develop next-generation antibody drug conjugate therapies targeting podocalyxin for the treatment of metastatic cancers. Their lead program aims to optimize an ADC for ovarian and pancreatic cancers, with the goal of rapid clinical translation. The company has not yet reported human clinical results but has received significant grant funding and support for preclinical optimization.

Therapeutic areas: Oncology
Modalities: Antibody Drug Conjugates (ADCs)immunotherapies
Industry: Biotech

Partnerships

iProgen Biotech [industry partner]GlycoNet Strategic Initiatives Grant / Canadian Glycomics Network Centre of Excellence [grant/funding partnership]University of British Columbia research teams led by Prof. Kelly M. McNagny & Prof. Calvin Roskelley [academic collaboration]

Beyond the preview

Go deeper on MetaStem Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MetaStem Therapeutics.

Explore the full profile